Rapid Micro Biosystems (NASDAQ:RPID) Issues Earnings Results

Rapid Micro Biosystems (NASDAQ:RPID) issued its quarterly earnings data on Friday. The company reported ($0.26) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.01, Zacks reports. The business had revenue of $7.21 million for the quarter, compared to analyst estimates of $6.63 million. Rapid Micro Biosystems had a negative return on equity of 48.05% and a negative net margin of 184.93%. Rapid Micro Biosystems updated its FY 2025 guidance to EPS.

Rapid Micro Biosystems Stock Performance

Shares of RPID stock opened at $3.08 on Friday. The stock has a 50 day simple moving average of $2.38 and a two-hundred day simple moving average of $1.85. The company has a market cap of $133.17 million, a P/E ratio of -2.75 and a beta of 1.13. Rapid Micro Biosystems has a fifty-two week low of $0.58 and a fifty-two week high of $4.04.

Analysts Set New Price Targets

Separately, KeyCorp started coverage on Rapid Micro Biosystems in a report on Wednesday, February 12th. They set an “overweight” rating and a $8.00 target price on the stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.